Aug 13, 2026 04:05PM
Jun 22, 2026 04:44PM
Jun 22, 2026 04:43PM
May 13, 2026 04:01PM
May 11, 2026 05:22PM
May 11, 2026 05:20PM
Apr 8, 2026 04:30PM FDA lifts partial clinical hold on MacroGenics' cancer drug study
Apr 8, 2026 04:30PM
Mar 10, 2026 05:03PM
Mar 9, 2026 04:01PM
Feb 24, 2026 04:29AM
Feb 23, 2026 06:14PM
Nov 12, 2025 04:01PM
Aug 14, 2025 04:01PM MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
May 13, 2025 04:01PM
Mar 20, 2025 04:02PM
Nov 5, 2024 04:01PM MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
Oct 30, 2024 07:30AM
Oct 30, 2024 07:30AM
Oct 22, 2024 07:30AM
Oct 22, 2024 07:30AM
Dec 19, 2023 05:30PM
Nov 6, 2023 04:01PM
Aug 9, 2023 04:01PM MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results
May 9, 2023 04:01PM
Mar 22, 2023 01:23PM
Mar 22, 2023 01:22PM
Mar 22, 2023 01:22PM
Mar 15, 2023 04:01PM
Nov 18, 2022 05:16AM
Nov 17, 2022 06:10PM MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
Nov 17, 2022 06:10PM
Nov 3, 2022 04:01PM
Aug 8, 2022 04:01PM
Jul 8, 2022 04:38PM
Jul 8, 2022 04:30PM
Jul 8, 2022 04:30PM
May 3, 2022 04:01PM MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results
Feb 24, 2022 04:01PM
Feb 24, 2022 04:01PM
Nov 2, 2021 04:01PM
Sep 16, 2021 05:47AM
Sep 16, 2021 02:45AM
Sep 16, 2021 02:45AM
Sep 7, 2021 04:34PM Macrogenics (MGNX) OS Results from SOPHIA Study of MARGENZA in Patients with HER2-Positive Metastatic Breast Cancer Did Not Demonstrate Statistically Significant Advantage
Sep 7, 2021 04:30PM

329,909 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All